why choose us

Clinical Trials Search

Showing 12,810 of 132,366 result(s)
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Status: Completed

Condition: Myotonic Dystrophy Type 2

Interventions: No intervention will be administered as part of this study.

Date: 2023-04-21

Continuous Glucose Monitoring and Diabetes

Status: Completed

Condition: Diabetes

Interventions: Participants will be provided with a device to monitor their blood glucose (Abbott Free Style Libre2 Flash CGM system) along with educational material

Date: 2023-04-21

Abbott Ventricular Tachycardia PAS

Status: Completed

Condition: Ventricular Tachycardia

Interventions: Subjects receive ablation treatment.

Date: 2023-04-21

An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions

Status: ACTIVE_NOT_RECRUITING

Condition: Metastatic Colorectal Cancer (mCRC)

Interventions: Oral multitargeted kinase inhibitor

Date: 2023-04-21

A Study of Doxycycline to Treat Chlamydial Infection

Status: COMPLETED

Condition: Chlamydial Infection

Interventions: Doxycycline is a synthetic tetracycline derivative with similar antimicrobial activity.

Date: 2023-04-21

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

Status: COMPLETED

Condition: Alzheimer's Disease

Interventions: Lighting intervention using high light levels designed to effect the circadian system

Date: 2023-04-20

A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors

Status: Completed

Condition: Solid Tumors, Adult

Interventions: Duration of infusion: HF158K1 is diluted using 5% (50 mg;ml) glucose injection or 0.9% sodium chloride injection (saline) to a total volume of 25

Date: 2023-04-20

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Status: Completed

Condition: Epidermolysis Bullosa

Interventions: Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)

Date: 2023-04-20

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Status: Completed

Condition: Schizophrenia

Interventions: A prescription digital therapeutic in the form of a smartphone app.

Date: 2023-04-20